Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92037


The purpose of this study is to obtain observational data allowing for the preliminary assessment of the utility of a noninvasive physiologic monitor for monitoring of patients with congestive heart failure.

Study summary:

The study proposes to utilize the CoVa™ Monitoring System, a novel body-worn sensor that remotely monitors thoracic fluid, heart rate, heart rate variability, respiration rate, skin temperature, posture, and, using transmitted waveforms, stroke volume and cardiac output to evaluate the system's monitoring capabilities in individuals recently hospitalized for congestive heart failure. The data acquired through this study will play a critical roll in developing future interventional studies that will allow patients with HF to potentially receive better and more timely treatment in the home setting, decreasing hospitalizations and improving quality of life.


Inclusion Criteria: - Adults over age 18 - Have wireless internet access within their homes. - Acute hospitalization with a primary diagnosis of acute decompensated heart failure (ADHF) diagnosed on the basis of all of the following: 1. Symptoms: - Onset or worsening of dyspnea within the past 2 weeks 2. Physical exam (at least 1 present): - Rales/ Crackles on auscultation - Elevated JVP > 8 cmH2O - Weight gain - LE edema 3. Diagnostic imaging/ labs (at least 1 present): - Evidence of pulmonary congestion or edema on chest X-ray/ chest CT - Elevated NT-pro-BNP (age-adjusted) (>1000) - Patients of particular interest will be those who already have a Medtronic Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy device with the OptiVol feature that tracks transthoracic impedance. Exclusion Criteria: - Allergy to ECG electrodes - Psychological or social situation that would make the study difficult for the patient - Inability to consent - Pregnant women - Pneumonia - currently, or within the past 30 days - Non-cardiogenic pulmonary edema (e.g. ARDS) - Interstitial lung disease - End-stage renal disease and on hemodialysis - For any reason unable to wear or place the CoVa™ device, e.g. pectus excavatum, fragile skin, severe arthritis.



Primary Contact:

Principal Investigator
Steven Steinhuble, MD
Scripps Translational Science Institute

Backup Contact:


Location Contact:

San Diego, California 92037
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.